Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients

A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)

Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, Stefania Paolillo, Francisco Alpendurada, Giovanni de Simone, Erwan Donal, Thomas Kahan, Giuseppe Mancia, Josep Redon, Roland Schmieder, Bryan Williams, Enrico Agabiti-Rosei

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.

Original languageEnglish
Pages (from-to)945-960
Number of pages16
JournalEuropean Heart Journal Cardiovascular Imaging
Volume18
Issue number9
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Hypertension
Cardiology
Mortality
Population
Therapeutics

Keywords

  • Journal Article

Cite this

Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients : A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH). / Perrone-Filardi, Pasquale; Coca, Antonio; Galderisi, Maurizio; Paolillo, Stefania; Alpendurada, Francisco; de Simone, Giovanni; Donal, Erwan; Kahan, Thomas; Mancia, Giuseppe; Redon, Josep; Schmieder, Roland; Williams, Bryan; Agabiti-Rosei, Enrico.

In: European Heart Journal Cardiovascular Imaging, Vol. 18, No. 9, 01.09.2017, p. 945-960.

Research output: Contribution to journalArticle

Perrone-Filardi, Pasquale ; Coca, Antonio ; Galderisi, Maurizio ; Paolillo, Stefania ; Alpendurada, Francisco ; de Simone, Giovanni ; Donal, Erwan ; Kahan, Thomas ; Mancia, Giuseppe ; Redon, Josep ; Schmieder, Roland ; Williams, Bryan ; Agabiti-Rosei, Enrico. / Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients : A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH). In: European Heart Journal Cardiovascular Imaging. 2017 ; Vol. 18, No. 9. pp. 945-960.
@article{e4064f0e4e414ebd825f3c9a01a60ab1,
title = "Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)",
abstract = "Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.",
keywords = "Journal Article",
author = "Pasquale Perrone-Filardi and Antonio Coca and Maurizio Galderisi and Stefania Paolillo and Francisco Alpendurada and {de Simone}, Giovanni and Erwan Donal and Thomas Kahan and Giuseppe Mancia and Josep Redon and Roland Schmieder and Bryan Williams and Enrico Agabiti-Rosei",
note = "{\circledC} The Authors, 2017. This article has been co-published in European Heart Journal - Cardiovascular Imaging and Journal of Hypertension The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article.",
year = "2017",
month = "9",
day = "1",
doi = "10.1093/ehjci/jex094",
language = "English",
volume = "18",
pages = "945--960",
journal = "European Heart Journal Cardiovascular Imaging",
issn = "2047-2404",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients

T2 - A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)

AU - Perrone-Filardi, Pasquale

AU - Coca, Antonio

AU - Galderisi, Maurizio

AU - Paolillo, Stefania

AU - Alpendurada, Francisco

AU - de Simone, Giovanni

AU - Donal, Erwan

AU - Kahan, Thomas

AU - Mancia, Giuseppe

AU - Redon, Josep

AU - Schmieder, Roland

AU - Williams, Bryan

AU - Agabiti-Rosei, Enrico

N1 - © The Authors, 2017. This article has been co-published in European Heart Journal - Cardiovascular Imaging and Journal of Hypertension The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.

AB - Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.

KW - Journal Article

U2 - 10.1093/ehjci/jex094

DO - 10.1093/ehjci/jex094

M3 - Article

VL - 18

SP - 945

EP - 960

JO - European Heart Journal Cardiovascular Imaging

JF - European Heart Journal Cardiovascular Imaging

SN - 2047-2404

IS - 9

ER -